Pharming Group N.V.
PHAR | NASDAQ
$12.65
+$0.42 (+3.43%)
Nov 2, 2026, 9:50 AM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 117.48M | 90.21M | 72.45M | 106.5M | 97.29M | 93.22M | 79.09M | 92.7B | 74.85M | 74.09M | 55.59M | 81.22M | 66.66M | 54.9M | 42.54M | 54.62M | 54.24M | 50.15M | 46.62M | 57.44M | 49.44M | 49.74M | 43.56M |
Cost of Revenue | 18.16M | 14.55M | 6.64M | 21.1M | 7.07M | 8.97M | 8.32M | 12.2B | 6.82M | 7.98M | 8.39M | 7.12M | 8.3M | 5.72M | 4.08M | 6.27M | 2.38M | 4.03M | 4.88M | 6.14M | 5.64M | 4.66M | 4.84M |
Gross Profit | 99.32M | 75.67M | 65.8M | 85.4M | 90.22M | 84.25M | 70.77M | 80.5B | 68.03M | 66.11M | 47.2M | 74.1M | 58.37M | 49.17M | 38.47M | 48.35M | 51.86M | 46.12M | 41.74M | 51.3M | 43.79M | 45.08M | 38.72M |
Operating Income | 27.67M | -111K | -5.29M | 2M | 15.75M | 9M | -7.43M | 6.6B | 3.33M | -3.12M | -16.31M | 1.07M | 1.91M | 5.3M | -13.66M | -10.18M | 7.76M | 17.82M | 2.83M | -1.28M | -2.08M | 10.83M | 6.28M |
Interest Income | n/a | n/a | 3.24M | n/a | 485K | 659K | 604K | 1.1M | 825K | 920K | 1.78M | n/a | 1.88M | n/a | 123K | -4.92M | 5.05M | -3.28M | 3.23M | n/a | n/a | n/a | 9.6M |
Pretax Income | 31.17M | 3.04M | -4.75M | 4.8M | 12.76M | 7.08M | -11.79M | 6.7B | 1.51M | -60K | -16.62M | -2.03M | 3.31M | 3.39M | -16.67M | -18.08M | 9.28M | 19.56M | 4.23M | 2.41M | 906.94K | 7.35M | 12.79M |
Net Income | 22.38M | 1.64M | -5.21M | 5.3M | 7.55M | 4.69M | -14.72M | 2.9B | -1.03M | -1.22M | -12.45M | -3.12M | 3.46M | 1.32M | -12.21M | -14.63M | 9.1M | 15.74M | 3.46M | 2.51M | -673.87K | 5.89M | 8.52M |
Selling & General & Admin | 42.08M | 43.52M | 45.53M | 51.3M | 51.08M | 51.55M | 57.06M | 51.6B | 43.98M | 48.55M | 45.34M | -30.48M | 36.01M | 44.89M | 37.09M | 30.12M | 32.4M | 27.95M | 24.93M | 17.43M | 21.1M | 21.83M | 22M |
Research & Development | 29.57M | 32.26M | 25.56M | 32.1M | 23.38M | 23.7M | 21.14M | 22.3B | 20.72M | 21.6M | 18.52M | 11.63M | 20.75M | 20.91M | 15.62M | 10.89M | 12.34M | 14.43M | 14.86M | 21.3M | 25.18M | 13.51M | 10.7M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -912K | -345K | 91.89M | -304K | -21.93M | -579K | 17.51M | -646K | -14.08M | -873K | 13.85M | -412.74K | -1.09M | -259K |
Operating Expenses | 71.65M | 75.78M | 71.09M | 83.4M | 74.47M | 75.25M | 78.2M | 73.9B | 64.7M | 69.23M | 63.51M | 73.03M | 56.46M | 43.87M | 52.13M | 58.52M | 44.09M | 28.3M | 38.92M | 52.59M | 45.87M | 34.25M | 32.44M |
Interest Expense | 2.7M | 2.68M | 2.7M | 1.4M | 7.95M | 4K | 5.1M | 1.25M | 3M | 1.97M | 1.56M | 4.54M | n/a | 2.46M | 2.8M | 1.38M | 1.25M | 1.35M | 1.38M | 1.94M | 1.5M | 1.54M | 1.88M |
Selling & Marketing Expenses | 29.46M | 28.57M | 30.32M | 31.3M | 34.13M | 31.05M | 34.57M | 26.9B | 28.69M | 32.93M | 30.25M | -79.32M | 25.12M | 33.91M | 27.11M | 28.98M | 20.37M | 19.25M | 17.2M | 16.97M | 14.17M | 13.91M | 14.84M |
Cost & Expenses | 89.81M | 90.32M | 77.74M | 104.5M | 81.54M | 84.22M | 86.52M | 86.1B | 71.52M | 77.21M | 71.9M | 80.15M | 64.75M | 49.6M | 56.2M | 64.8M | 46.47M | 32.33M | 43.79M | 58.72M | 51.52M | 38.91M | 37.28M |
Income Tax Expense | 8.79M | 1.4M | 459K | -500K | 5.21M | 2.53M | 3.1M | 3.8B | 2.55M | 1.16M | -4.18M | 1.09M | -157K | 2.07M | -4.47M | -3.45M | 178K | 3.82M | 772K | -95.49K | 1.58M | 1.46M | 4.27M |
Shares Outstanding (Basic) | 70.78M | 70.14M | 70.14M | 66.28M | 66.9M | 66.9M | 66.9M | 68.03M | 64.63M | 84.79M | 83.88M | 83.88M | 82.04M | 65.92M | 82.04M | 82.04M | 83.05M | 86.53M | 86.53M | 80.25M | 63.81M | 80.13M | 79.76M |
Shares Outstanding (Diluted) | 74.67M | 70.14M | 70.14M | 75.77M | 66.9M | 66.9M | 66.9M | 68.03M | 64.63M | 84.79M | 83.88M | 83.88M | 82.04M | 65.92M | 82.04M | 82.04M | 86.53M | 86.53M | 86.53M | 87.64M | 63.81M | 80.13M | 81.95M |
EPS (Basic) | 0.32 | 0.02 | -0.07 | 0.08 | 0.11 | 0.07 | -0.22 | 0.05 | -0.02 | -0.01 | -0.15 | -0.04 | 0.05 | 0.02 | -0.15 | -0.18 | 0.11 | 0.18 | 0.04 | 0.03 | -0.01 | 0.07 | 0.12 |
EPS (Diluted) | 0.30 | 0.02 | -0.07 | 0.07 | 0.11 | 0.07 | -0.22 | 0.05 | -0.02 | -0.01 | -0.15 | -0.04 | 0.05 | 0.02 | -0.15 | -0.18 | 0.10 | 0.18 | 0.04 | 0.03 | -0.01 | 0.07 | 0.12 |
EBITDA | 30.44M | 8.75M | 1.06M | 9.41M | 23.43M | 9.79M | -4.11M | 6.71B | 7.26M | 1.91M | -9.15M | 6.87M | 4.81M | 6.72M | -11.57M | -9.73M | 12.48M | 22.98M | 7.8M | 16.89M | 4.65M | 11.18M | 16.45M |
EBIT | 27.67M | 5.72M | -2.06M | 6.2M | 20.7M | 7.08M | -6.69M | 6.7B | 4.51M | 1.91M | -15.07M | -688K | 1.91M | 3.56M | -13.88M | -16.7M | 10.53M | 20.91M | 5.61M | 4.18M | 2.31M | 8.72M | 14.39M |
Depreciation & Amortization | 2.77M | 3.04M | 3.12M | 3.21M | 2.73M | 2.7M | 2.58M | 7.7M | 2.74M | n/a | 5.92M | 7.56M | 2.9M | 3.16M | 2.31M | 6.97M | 1.95M | 2.07M | 2.19M | 12.71M | 2.34M | 2.46M | 2.06M |
Add to Watchlist
Select watchlists to add or remove PHAR